Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivo

Rensing‐Ehl, Anne, Frei, Karl, Flury, Renata, Matiba, Bernd, Mariani, Sara M., Weller, Michael, Aebischer, Patrick, Krammer, Peter H., Fontana, Adriano · 1995 · European Journal of Immunology

Abstract

Fas/APO‐1 (CD95) is a cell surface receptor which mediates apoptosis when ligated by specific antibodies or by its recently cloned natural ligand, FasL. We have studied the cytotoxic potential of FasL in vivo using Fas/APO‐1‐expressing Yac‐1 cells as targets. Supernatant harvested from Neuro‐2a cells transfected with the murine FasL cDNA contains FasL and transduces a potent apoptotic signal to Yac‐1 cells in vitro. Specificity of FasL‐mediated cytotoxicity was confirmed by competition assays using soluble Fas or anti‐Fas/APO‐1 F(ab')2 fragments which specifically interfere with FasL‐Fas/APO‐1 interactions. Intraperitoneal injection of FasL‐containing supernatant efficiently killed Yac‐1 target cells which had been implanted in capsules into the peritoneal cavity of mice. Analysis of the target cells revealed DNA fragmentation and nuclear changes typical of apoptosis. As previously shown, intraperitoneal injection of anti‐Fas/APO‐1 antibodies caused liver failure (Ogasawara, J., Watanabe, F. R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T. and Nagata, S., Nature 1993. 364: 806) and was observed at doses which did not reduce Yac‐1 cell viability. In contrast, FasL did not induce histopathology in the liver when applied intraperitoneally at doses cytotoxic for Yac‐1 cells. However, intravenous administration of FasL induced lethal liver hemorrhages and hepatocyte apoptosis. Thus, locally applied FasL kills tumor cells very efficiently without systemic toxicity and may therefore represent a candidate for local tumor treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.1830250821

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 191

Metadata

Authors
Rensing‐Ehl, A., Frei, K., Flury, R., Matiba, B., Mariani, S. M., Weller, M., Aebischer, P., Krammer, P. H., & Fontana, A.
Venue
European Journal of Immunology
Publisher
Wiley
Published
1995-08
Volume
25
Issue
8
Pages
2253-2258
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2083363077
Cited by
191
References
1
FWCI
6.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivo. https://app.cochat.ai/papers/10.1002/eji.1830250821
The paper
Rensing‐Ehl, A., Frei, K., Flury, R., Matiba, B., Mariani, S. M., Weller, M., Aebischer, P., Krammer, P. H., & Fontana, A. (1995). Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivo. European Journal of Immunology. https://doi.org/10.1002/eji.1830250821

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.